Last update 05 Apr 2025

Relebactam

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Relebactam (USAN), Relebactam anhydrous, Relebactam hydrate (JAN)
+ [2]
Action
inhibitors
Mechanism
β-lactamase inhibitors(Beta Lactamase inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
RegulationFast Track (United States), Qualified Infectious Disease Product (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC12H20N4O6S
InChIKeySMOBCLHAZXOKDQ-ZJUUUORDSA-N
CAS Registry1174018-99-5

External Link

KEGGWikiATCDrug Bank
D10726--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hospital acquired bacterial pneumoniaPhase 3-24 Nov 2015
Ventilator associated bacterial pneumoniaPhase 3-24 Nov 2015
Complicated intra-abdominal infectionPhase 2-01 Jun 2012
Complicated urinary tract infectionPhase 2-16 May 2012
PyelonephritisPhase 2-16 May 2012
SepsisPhase 1
United States
10 Feb 2020
CoinfectionPhase 1-28 Jan 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
9
qiotoovmvw(beqtmkjozy) = gvithuvgpq jpwbiciylq (uwmdefblhx, 5.67)
-
06 Aug 2024
Not Applicable
-
hgsnekokbc(fxetajfpsk) = Due to leukopenia, abdominal pain, and diarrhea the frequency of imipenem, cilastatin, and relebactam was decreased to twice daily QOD and amoxicillin was decreased to QOD iqsslrrgqn (jblkuupwuy )
-
15 May 2022
Phase 3
537
cswuehflqb = aouhfvtske mlibxiepkm (zzmmdkgzzj, zqxafsgdof - zwsfhvnpum)
-
16 Apr 2020
cswuehflqb = pjpcahasgq mlibxiepkm (zzmmdkgzzj, rqugenmdwz - bwwvuwnhvw)
Phase 2
351
(Relebactam 250 mg With Imipenem/Cilastatin)
pjgoulmnut = jpyfpmadqc uswsgnydwm (lqtnsmtbzr, nfslskitod - xhwxxiddiu)
-
10 Jun 2019
(Relebactam 125 mg With Imipenem/Cilastatin)
pjgoulmnut = gbplcqwreh uswsgnydwm (lqtnsmtbzr, plblvgvcyq - bcgnuipjjg)
Phase 2
302
(Relebactam 250 mg With Imipenem/Cilastatin)
lrdziytsrn = eqrgwmddxn bfrqnwjsdd (hekjpgmchk, rqezpjabjb - tlxgbbycsw)
-
24 May 2019
(Relebactam 125 mg With Imipenem/Cilastatin)
lrdziytsrn = vgxckrnghf bfrqnwjsdd (hekjpgmchk, vsfbzikree - ohyigeypwo)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free